Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by G1945V


V.VPT

RE:Criticism

GrahamB wrote: “One mustn't criticize other people on grounds where he...

May 31, 2023

V.QPT

Audited Financial Statements/Report

January 31, 2023, due today. G1945V

May 31, 2023

V.QPT

Annual General Meeting

July 13, 2023 Time TBD Meeting Location (if available): Hybrid Meeting...

May 30, 2023

V.VPT

In my inbox @ 9:47 AM- May 30, 2023

"Dear Friend;   Attached are two press releases that the...

May 30, 2023

V.WATR

RE:Q1 on sedar

lscfa wrote: $1 miilion revenue. No breakout but assume $337,500 ($250,000 US...

May 30, 2023

V.VPT

News Release May 30, 2023

Ventripoint Receives European Union Medical Device Regulation Certification...

May 30, 2023

V.VPT

RE:First quarter numbers

shawshank666 wrote: Last year the numbers were out on May 30 so maybe we will...

May 29, 2023

V.VPT

RE:Unbeliveable

GrahamB wrote: So we have a few posts that are misleading at best. An old...

May 25, 2023

V.VPT

RE:RE:RE:RE:RE:RE:THE VMS + INNOVATION ADVANTAGE

GrahamB wrote: G1945V wrote: GrahamB wrote: You keep reposting the same old...

May 24, 2023

V.VPT

RE:RE:RE:RE:THE VMS + INNOVATION ADVANTAGE

GrahamB wrote: You keep reposting the same old ads BTW how is it unique when...

May 23, 2023

V.QPT

WEBSITE UPDATED

             ...

May 19, 2023

PMN

RE:RE:Frustrated Colleagues

M101 wrote: Why choose? If Promis makes a partnership deal with no cash on...

May 19, 2023

V.VPT

RE:RE:RE:New Press Release - Ventripoint Issues Option Grants and Reports Exercise of Options

Pandora wrote: Just wondering if this news is a regulatory requirement or...

May 18, 2023

V.VPT

RE:Accessible cardiac imaging is a goal for our product design

jopatclo wrote: Ventripoint Diagnostics ...

May 17, 2023

PMN

RE:RE:Partner Time

BottomBroker wrote: What would a partner deal look like do you think? How...

May 17, 2023

T.MSCL

Satellos closes $55M Financing

Satellos Bioscience Closes $55M Financing to Support Development of its Lead...

May 17, 2023

PMN

RE:Pretty Quiet / Gov Clinical Trials

FarmerBetty wrote: Tried to find Promis listed under US gov clinical trials...

May 17, 2023

V.VPT

RE:RE:RE:All Aboard !!

Pandora wrote: Not a lot of action here today. About 10K - 11K on all...

May 16, 2023

V.NSP.H

Insolvency of Subsidiary-

NSP, Announces Insolvency of Subsidiary, But Naturally Splendid Enterprises...

May 15, 2023

PMN

RE:RE:RE:RE:New Press Release - ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer's Disease

bball67 wrote: My conjecture is it will be in 2-3 months, when 1a trial is...

May 8, 2023

Featured Company